Information Provided By:
Fly News Breaks for February 15, 2019
Feb 15, 2019 | 07:46 EDT
JPMorgan analyst Kenneth Worthington resumed coverage of CME Group following a period of restriction and downgraded the shares to Underweight from Neutral with a $164 price target. While the analyst believes CME's acquisition of NEX can be "potentially disruptive over time," he sees near term risks from elevated expectations, difficult 2018 comparisons and soft volumes.
News For CME From the Last 2 Days
There are no results for your query CME